A low‐saturated‐fat, low‐cholesterol diet decreases plasma CETP activity and pre β‐HDL formation but does not affect cellular cholesterol efflux to plasma from type 1 diabetic patients

References

• Truswell A. S. Review of dietary intervention studies: effect on coronary events and on total mortality. Aust NZ J Med 1994; 24: 98–106
   PubMedGoogle Scholar
• Krolewski A. S., Kosinski E. J., Warram J. H., Leland O. S., Busick E. J., Asmal A. C., et al. Magnitude and determinants of coronary artery disease in juvenile‐onset, insulin‐dependent diabetes mellitus. Am J Cardiol 1987; 59: 750–5
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Nutrition principles and recommendations in diabetes. Diab Care 2004; 27: S36–46
   PubMedGoogle Scholar
• Mensink R. P., Katan M. B. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta‐analysis of 27 trials. Arterioscler Thromb 1992; 12: 911–19
   PubMed Web of Science ®Google Scholar
• Blanco‐Molina A., Castro G., Martin‐Escalante D., Bravo D., Lopez‐Miranda J., Castro P., et al. Effects of different dietary cholesterol concentrations on lipoprotein plasma concentrations and on cholesterol efflux from Fu5AH cells. Am J Clin Nutr 1998; 68: 1028–33
   PubMedGoogle Scholar
• Jansen S., Lopez‐Miranda J., Castro P., Lopez‐Segura F., Marton C., Ordovas J. M., et al. Low‐fat and high monounsaturated fatty acid diets decrease plasma cholesterol ester transfer protein concentrations in young, healthy, normolipemic men. Am J Clin Nutr 2000; 72: 36–41
   PubMed Web of Science ®Google Scholar
• Martin L. J., Connelly P. W., Nancoo D., Wood N., Zhang Z. J., Maguire G., et al. Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apo‐E genotype. J Lipid Res 1993; 34: 437–46
   PubMedGoogle Scholar
• Blaauwwiekel E. E., Beusekamp B. J., Sluiter W. J., Hoogenberg K., Dullaart R. P. F. Apolipoprotein E genotype is a determinant of low‐density lipoprotein cholesterol and of its response to a low‐cholesterol diet in Type 1 diabetic patients with elevated urinary albumin excretion. Diabet Med 1998; 15: 1031–5
   PubMedGoogle Scholar
• Fielding C. J., Fielding P. E. Molecular physiology of reverse cholesterol transport. J Lipid Res 1995; 36: 211–28
   PubMed Web of Science ®Google Scholar
• Barter P. J., Rye K. A. High density lipoproteins and reverse cholesterol transport. Curr Opin Lipidol 1993; 4: 210–17
   Google Scholar
• Jauhiainen M., Metso J., Pahlman R., Blomqvist S., Van Tol A., Ehnholm C. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem 1993; 268: 4032–6
   PubMed Web of Science ®Google Scholar
• Rye K. A., Clay M. A., Barter P. J. Remodelling of high density lipoproteins by plasma factors. Atherosclerosis 1999; 145: 227–38
   PubMed Web of Science ®Google Scholar
• Miida T., Yamaguchi H., Tsuda T., Okada M. High pre‐beta1‐HDL levels in hypercholesterolemia are maintained by probucol but reduced by a low‐cholesterol diet. Atherosclerosis 1998; 138: 129–34
   PubMedGoogle Scholar
• Sola R., Motta C., Maille M., Bargallo M. T., Boisnier C., Richard J. L., et al. Dietary monounsaturated fatty acids enhance cholesterol efflux from human fibroblasts. Relation to fluidity, phospholipid fatty acid composition, overall composition, and size of HDL3. Arterioscler Thromb 1993; 13: 958–66
   PubMedGoogle Scholar
• Gillotte K. L., Lund‐Katz S., De La Llera‐Moya M., Parks J. S., Rudel L. L., Rothblat G. H., et al. Dietary modification of high density lipoprotein phospholipid and influence on cellular cholesterol efflux. J Lipid Res 1998; 39: 2065–75
   PubMed Web of Science ®Google Scholar
• Van Staveren W. A., Hulshof K. F. A. M. De voedingsanamnese in het voedingsonderzoek, mogelijkheden en beperkingen. Voeding 1980; 41: 228–32
   Google Scholar
• Dullaart R. P. F., Sluiter W. J., Dikkeschei L. D., Hoogenberg K., Van Tol A. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest 1994; 24: 188–94
   PubMed Web of Science ®Google Scholar
• Speijer H., Groener J. E., Van Ramshorst E., Van Tol A. Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma. Atherosclerosis 1991; 90: 159–68
   PubMed Web of Science ®Google Scholar
• Groener J. E., Pelton R. W., Kostner G. M. Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin Chem 1986; 32: 283–6
   PubMed Web of Science ®Google Scholar
• Van Haperen R., Van Tol A., Vermeulen P., Jauhiainen M., Van Gent T., Van den Berg P., et al. Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice. Arterioscler Thromb Vasc Biol 2000; 20: 1082–8
   PubMedGoogle Scholar
• Brussaard J. H., Dallinga‐Thie G. M., Groot P. H. E., Katan M. B. Effects of amount and type of dietary fat on serum lipids, lipoproteins and apolipoproteins in man. A controlled 8‐week trial. Atherosclerosis 1980; 36: 515–27
   PubMed Web of Science ®Google Scholar
• Hovingh G. K., Wijland M. J., Brownlie A., Bisoendial R. J., Hayden M. R., Kastelein J. J., et al. The role of the ABCA1 transporter and cholesterol efflux in familial hypoalphalipoproteinemia. J Lipid Res 2003; 44: 1251–5
   PubMed Web of Science ®Google Scholar
• Denis M., Bissonnette R., Haidar B., Krimbou L., Bouvier M., Genest J. Expression, regulation, and activity of ABCA1 in human cell lines. Mol Genet Metab 2003; 78: 265–74
   PubMedGoogle Scholar
• Gillotte‐Tayler K., Nickel M., Johnson W. J., Francone O. L., Holvoet P., Rothblat G. H., et al. Effects of enrichment of fibroblasts with unesterified cholesterol on the efflux of cellular lipids to apolipoprotein A–I. J Biol Chem 2002; 277: 11811–20
   PubMedGoogle Scholar
• Dullaart R. P. F., Van Tol A. Twenty‐four hour‐insulin infusion impairs the ability of plasma from healthy subjects and type 2 diabetic patients to promote cellular cholesterol efflux. Atherosclerosis 2001; 157: 49–56
   PubMedGoogle Scholar
• Rothblat G. H., De La Llera‐Moya M., Atger V., Kellner‐Weibel G., Williams D. L., Phillips M. C. Cell cholesterol efflux: integration of old and new observations provides new insights. J Lipid Res 1999; 40: 781–96
   PubMed Web of Science ®Google Scholar
• De La Llera‐Moya M., Atger V., Paul J. L., Fournier N., Moatti N., Giral P., et al. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer. Arterioscler Thromb 1994; 14: 1056–65
   PubMedGoogle Scholar
• Wang N., Lan D., Chen W., Matsuura F., Tall A. R. ATP‐binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high‐density lipoproteins. Proc Natl Acad Sci USA 2004; 101: 9774–9
   PubMed Web of Science ®Google Scholar
• Fournier N., Paul J. L., Atger V., Cogny A., Soni T., De La Llera‐Moya M., et al. HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum. Arterioscler Thromb Vasc Biol 1997; 17: 2685–91
   PubMed Web of Science ®Google Scholar
• Castro G. R., Fielding C. J. Early incorporation of cell‐derived cholesterol into pre‐b‐migrating high‐density lipoprotein. Biochemistry 1988; 27: 25–9
   PubMed Web of Science ®Google Scholar
• Oram J., Wolfbauer G., Vecchio G., Albers J. J. Phospholipid transfer protein interacts with and stabilizes ATP‐binding cassette transporter A1 and enhances cholesterol efflux from cells. J Biol Chem 2003; 26: 52379–85
   Google Scholar
• Montoya M. T., Porres A., Serrano S., Fruchart J. C., Mata P., Gómez Gerique J. A., et al. Fatty acid saturation of the diet and plasma lipid concentrations, lipoprotein particle concentrations, and cholesterol efflux capacity. Am J Clin Nutr 2002; 75: 484–91
   PubMed Web of Science ®Google Scholar
• Meijer G. W., Groener J. E., Beynen A. C., Van Tol A. Lowering of serum cholesteryl ester transfer protein – but not lecithin:cholesterol acyltransferase – activity levels by hypocholesterolemic drugs in the rabbit. Cardiovasc Drugs Ther 1998; 12: 13–18
   PubMed Web of Science ®Google Scholar
• Lichtenstein A. H., Ausman L. M., Jalbert S. M., Vilella‐Bach M., Jauhiainen M., McGladdery S., et al. Efficacy of a Therapeutic Lifestyle Change/Step 2 diet in moderately hypercholesterolemic middle‐aged and elderly female and male subjects. J Lipid Res 2002; 43: 264–73
   PubMedGoogle Scholar
• Dullaart R. P. F., De Vries R., Scheek L. M., Borggreve S. E., Van Gent T., Dallinga‐Thie G. M., et al. Type 2 diabetes mellitus is associated with differential effects on plasma cholesteryl ester transfer protein and phospholipid transfer protein activities and concentrations. Scand J Clin Lab Invest 2004; 64: 205–16
   PubMed Web of Science ®Google Scholar
• McPherson R., Lau P., Kussie P., Tall A. R. Plasma kinetics of cholesteryl ester transfer protein in the rabbit. Effects of dietary cholesterol. Arterioscler Thromb Vasc Biol 1997; 17: 203–10
   PubMedGoogle Scholar
• Rye K. A., Jensen G., Barter P. J., Ehnholm C. Triglyceride‐enrichment of high density lipoproteins enhances their remodelling by phospholipid transfer protein. J Lipid Res 1998; 39: 613–22
   PubMed Web of Science ®Google Scholar
• Boekholdt S. M., Kuivenhoven J. A., Hovingh G. K., Jukema J. W., Kastelein J. J. P., Van Tol A. CETP gene variation: relation to lipid parameters and cardiovascular risk. Curr Opin Lipidol 2004; 15: 393–8
   PubMedGoogle Scholar